Tibet Rhodiola Pharmaceutical Holding Co. Class ASSE: 600211

"Tibet Rhodiola Pharmaceutical Holding Co."Announcement on Convening the 2026 Semi-annual Performance Briefing

Aug 25, 2026 · Issued by Tibet Rhodiola Pharmaceutical Holding Co. Class A via Shanghai Stock Exchange

Announcement on Convening the 2026 Semi-annual Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Tibet Rhodiola Pharmaceutical Holding Co. Class A

"Tibet Rhodiola Pharmaceutical Holding Co."Announcement on Resolutions of the 2nd Meeting of the 9th Board of DirectorsAug 14
"Tibet Rhodiola Pharmaceutical Holding Co."Announcement on Progress in Providing Guarantee for Controlled SubsidiaryJul 16
"Tibet Rhodiola Pharmaceutical Holding Co."Announcement on Progress in Share RepurchaseJul 2
Announcement on Release of Pledge of Some Shares Held by Shareholders with Over 5% SharesJun 5

All Tibet Rhodiola Pharmaceutical Holding Co. Class A news releases